ROCA predicts the probability of ovarian cancer based on serial measurements of serum CA125, exploiting the frequently observed phenomenon that ovarian cancer's initial development causes a change-point in these levels over a woman's individual baseline [9, 10]. Here, MUC16 is linked to ovarian cancer.